Biora Therapeutics Analyst Ratings
Biora Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Biora Therapeutics (BIOR) rating was a maintained with a price target of $65.00 to $50.00. The current price Biora Therapeutics (BIOR) is trading at is $2.17, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/02/2023 | 2204.15% | HC Wainwright & Co. | $65 → $50 | Maintains | Buy |
| 08/15/2023 | 2895.39% | HC Wainwright & Co. | → $65 | Reiterates | Buy → Buy |
| 07/27/2023 | 2895.39% | HC Wainwright & Co. | → $65 | Reiterates | Buy → Buy |
| 05/16/2023 | 2895.39% | HC Wainwright & Co. | → $65 | Reiterates | Buy → Buy |
| 01/10/2023 | 2895.39% | HC Wainwright & Co. | $6 → $65 | Maintains | Buy |
| 日期 | 上行/下行 | 分析师事务所 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2023 年 2 月 10 日 | 2204.15% | HC Wainwright & Co. | 65 美元 → 50 美元 | 维护 | 购买 |
| 08/15/2023 | 2895.39% | HC Wainwright & Co. | → 65 美元 | 重申 | 购买 → 购买 |
| 07/27/2023 | 2895.39% | HC Wainwright & Co. | → 65 美元 | 重申 | 购买 → 购买 |
| 05/16/2023 | 2895.39% | HC Wainwright & Co. | → 65 美元 | 重申 | 购买 → 购买 |
| 01/10/2023 | 2895.39% | HC Wainwright & Co. | 6 美元 → 65 美元 | 维护 | 购买 |
What is the target price for Biora Therapeutics (BIOR)?
Biora Therapeutics（BIOR）的目标价格是多少？
The latest price target for Biora Therapeutics (NASDAQ: BIOR) was reported by HC Wainwright & Co. on October 2, 2023. The analyst firm set a price target for $50.00 expecting BIOR to rise to within 12 months (a possible 2204.15% upside). 5 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年10月2日公布了Biora Therapeutics（纳斯达克股票代码：BIOR）的最新目标股价。该分析公司将目标股价定为50.00美元，预计BIOR将在12个月内上涨至50.00美元（可能上涨2204.15％）。去年有5家分析公司公布了评级。
What is the most recent analyst rating for Biora Therapeutics (BIOR)?
Biora Therapeutics（BIOR）的最新分析师评级是多少？
The latest analyst rating for Biora Therapeutics (NASDAQ: BIOR) was provided by HC Wainwright & Co., and Biora Therapeutics maintained their buy rating.
Biora Therapeutics（纳斯达克股票代码：BIOR）的最新分析师评级由HC Wainwright & Co. 提供，Biora Therapeutics维持买入评级。
When is the next analyst rating going to be posted or updated for Biora Therapeutics (BIOR)?
Biora Therapeutics（BIOR）的下一个分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biora Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biora Therapeutics was filed on October 2, 2023 so you should expect the next rating to be made available sometime around October 2, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Biora Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Biora Therapeutics的最后一次评级是在2023年10月2日提交的，因此您应该预计下一个评级将在2024年10月2日左右公布。
Is the Analyst Rating Biora Therapeutics (BIOR) correct?
分析师对Biora Therapeutics（BIOR）的评级是否正确？
While ratings are subjective and will change, the latest Biora Therapeutics (BIOR) rating was a maintained with a price target of $65.00 to $50.00. The current price Biora Therapeutics (BIOR) is trading at is $2.17, which is out of the analyst's predicted range.
尽管评级是主观的，并将发生变化，但最新的Biora Therapeutics（BIOR）评级维持不变，目标股价为65.00美元至50.00美元。Biora Therapeutics（BIOR）目前的交易价格为2.17美元，超出了分析师的预期区间。
